Overview
Valued at ~$11.7 billion in 2023, the hemodialysis consumables market is projected to reach
~$14.2 billion by 2028, increasing at a CAGR of 3.9% over the 2023-2028
forecast period. This Market Snapshot is part of LSI’s Market Intelligence platform, your
one-stop-shop for global medtech market sizing and analysis, procedure volume data, startup company- and
deal-tracking, curated insights, and more.
The hemodialysis consumables market encompasses products employed in the treatment and management of two major
conditions:
Acute kidney injury (AKI)
End-stage renal disease (ESRD)
Hemodialysis catheters provide access to the patient’s blood, while dialyzers are filters that remove waste from
blood using a dialysis solution and return the filtered blood to the body.
Products included within the scope of this analysis include:
Dialyzers
Hemodialysis catheters
This Market Snapshot is intended to provide a high-level overview of the global market for dialyzers and
hemodialysis catheters, with key insights into:
Unit volumes from 2023 to 2028
Market forecasts from 2023 to 2028
Market insights
Competitive landscape analysis of major competitors
Insights into key market events for strategic and startups
Hemodialysis Consumables Market Snapshot Summary
| Snapshot Aspect | Data and Details |
| Base Year for Estimate | 2023 |
| Forecast Period | 2023 - 2028 |
| Market Size in 2023 | $11.7 billion |
| CAGR | 3.9% |
| Projected Market Size in 2028 | $14.2 billion |
Hemodialysis Consumables Market Insights
The hemodialysis consumables market is positioned for continued growth, primarily driven by the rising
prevalence of ESRD and the increasing global burden of diabetes and hypertension. With over 4.1 million patients
receiving dialysis treatments worldwide, of which 89% are undergoing hemodialysis, the demand for effective
renal replacement therapies is higher than ever. According to the U.S. Renal Data System, the prevalence of ESRD
nearly doubled between 2001 and 2021.
Diabetes is a major contributor to the increasing ESRD rates, accounting for more than 60% of new cases in 2021.
The International Diabetes Federation forecasts a 46% rise in the global prevalence of diabetes by 2045,
highlighting the long-term demand for hemodialysis. Additionally, hypertension—which affected approximately 1.28
billion individuals worldwide in 2023—is the second most common cause of ESRD, particularly in lower-income
countries.
The market’s competitive landscape features leading suppliers such as Baxter and Fresenius, who provide a range
of products, including consumables and dialysis equipment. Baxter is currently exploring strategic options
regarding its Kidney Care and Acute Therapies business, which could lead to shifts in market dynamics and
opportunities for other players to expand their footprint.
Competitive Landscape
The full Market Snapshot includes a robust analysis of the competitive landscape for the hemodialysis
consumables market. This includes estimated market revenue and market share for key players like Nipro, Baxter,
and Fresenius Medical Care.
Select Market Events
| Company | Date | Event Type | Event |
|
Baxter
|
5/2024 | Clinical Study | Baxter announced the results of a cohort study that showed Baxter’s HDx therapy is associated with an approximately 25% lower mortality rate compared to high-flux hemodialysis for up to 4 years. |
|
Fresenius Medical Care
|
1/2024 | Product Recall | Fresenius recalled over 2 million Stay-SafeⓇ Catheter Extension Sets and Stay-Safe/Luer Lock Adapters in a Class I recall due to toxic NDL-PCBA leakage. No injuries or deaths have been reported. |
Key Companies Covered
Asahi Kasei
B. Braun
Baxter
Bellco
Fresenius Medical Care
Humacyte
Intermedt
Inspira Health
Nikkiso Medical
NxStage
Rockwell Medical
Teleflex
Terumo
Toray Medical
TVA Medical
Nipro
